9995.HK Current Ratio

The Current Ratio of RemeGen Co Ltd (9995.HK) is 3.73.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

9995.HK Current Ratio - Historical Value

Date	Value
2020-12-31	3.73
2019-12-31	0.16
2018-12-31	0.07

9995.HK Current Ratio - Peers Comparison

Ticker	Name	Value
000403.SZ	Pacific Shuanglin Bio-pharmacy Co Ltd	3.74
300149.SZ	ChemPartner PharmaTech Co Ltd	1.86
688363.SS	Bloomage Biotechnology Corp Ltd	2.04
9926.HK	Akeso Inc	5.15
1875.HK	TOT BIOPHARM International Co Ltd	1.79
2126.HK	JW (Cayman) Therapeutics Co Ltd	4.78
4587.T	PeptiDream Inc	3.11
688177.SS	Bio-Thera Solutions Ltd	0.81
9939.HK	Kintor Pharmaceutical Ltd	4.74
002007.SZ	Hualan Biological Engineering Inc	4.07
002252.SZ	Shanghai RAAS Blood Products Co Ltd	5.60
300142.SZ	Walvax Biotechnology Co Ltd	2.98
6978.HK	Immunotech Biopharm Ltd	0.20
300676.SZ	BGI Genomics Co Ltd	2.42
9969.HK	InnoCare Pharma Ltd	19.49
1167.HK	Jacobio Pharmaceuticals Group Co Ltd	4.89
2181.HK	Mabpharm Ltd	1.17
600161.SS	Beijing Tiantan Biological Products Corp Ltd	6.89
688180.SS	Shanghai Junshi Biosciences Co Ltd	1.72
300832.SZ	Shenzhen New Industries Biomedical Engineering Co Ltd	5.56
603087.SS	Gan & Lee Pharmaceuticals	4.73
688266.SS	Suzhou Zelgen Biopharmaceuticals Co Ltd	2.22
000504.SZ	Landfar Bio medicine Co Ltd	1.45
6998.HK	Genor Biopharma Holdings Ltd	8.74
9966.HK	Alphamab Oncology	6.74
300653.SZ	Yantai Zhenghai Bio-Tech Co Ltd	8.82
6855.HK	Ascentage Pharma Group International	1.26
688520.SS	Sinocelltech Group Ltd	0.73